Importance of CsA drug monitoring in SCT recipients to minimize GVHD and maximize graft vs. leukemia.
Barkholt
Lisbeth
L
D016572:Cyclosporine / Q000097:blood*; D016903:Drug Monitoring; D006086:Graft vs Host Disease / Q000517:prevention & control*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood*; D007938:Leukemia / Q000628:therapy*; D014181:Transplantation Immunology / Q000276:immunology*
D007166:Immunosuppressive Agents; D016572:Cyclosporine